chronic myeloid leukemia (cml)
Showing 1 - 17 of 17
Chronic Myeloid Leukemia (CML) Trial in France
Recruiting
- Chronic Myeloid Leukemia (CML)
-
Annecy, France
- +11 more
Jul 18, 2023
Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute
Completed
- Chronic Myeloid Leukemia (CML)
- +4 more
- Bortezomib
- NK cells
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 31, 2022
Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,
Active, not recruiting
- Acute Lymphoid Leukemia (ALL)
- +5 more
- Hyperfractionated total body irradiation
- +9 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- +7 more
- Cyclophosphamide
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 8, 2021
Chronic Myeloid Leukemia (CML) Trial in Nanjing ([14C] HQP1351)
Completed
- Chronic Myeloid Leukemia (CML)
- [14C] HQP1351
-
Nanjing, ChinaThe First Affiliated Hospital with Nanjing Medical University
Sep 7, 2021
Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial run by the NHLBI
Completed
- Myelodysplastic Syndrome (MDS)
- +2 more
- WT1:126-134
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 15, 2021
Chronic Myeloid Leukemia (CML) Trial in Italy (Ponatinib 15mg QD, Ponatinib 30mg QD)
Not yet recruiting
- Chronic Myeloid Leukemia (CML)
- Ponatinib 15mg QD
- Ponatinib 30mg QD
-
Cagliari, Italy
- +12 more
Jan 31, 2021
Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (CliniMACS
Recruiting
- Chronic Myeloid Leukemia (CML)
- +5 more
- CliniMACS CD34+ Reagent System
- +8 more
-
New York, New YorkColumbia University Medical Center
Jun 17, 2020
EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia
Unknown status
- Chronic Myeloid Leukemia (CML)
- Chronic Phase
- Collection of blood and bone marrow
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand
Oct 8, 2018
Chronic Myeloid Leukemia (CML) Trial in France (Pioglitazone + TKI)
Unknown status
- Chronic Myeloid Leukemia (CML)
- Pioglitazone + TKI
-
Le Chesnay, France
- +3 more
Mar 20, 2018
Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Trial in United States
Approved for marketing
- Chronic Myeloid Leukemia (CML)
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
-
La Jolla, California
- +32 more
Feb 5, 2018
Chronic Myeloid Leukemia (CML) Trial in Seoul (Imatinib/Acetaminophen)
Completed
- Chronic Myeloid Leukemia (CML)
-
Seoul, Korea, Republic ofNovartis Investigative Site
Apr 20, 2016
Healthcare Costs Among CML Receiving Dasatinib or Nilotinib
Completed
- Chronic Myeloid Leukemia (CML)
-
Clinton, South CarolinaFranklin Pharmaceutical Consulting, Llc
Jul 3, 2015
Myelodysplastic Syndrome, Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial run by the NHLBI (WT1 Peptide
Completed
- Myelodysplastic Syndrome
- +2 more
- WT1 Peptide Vaccine
-
Bethesda, MarylandNational Cancer Institute (NCI), 9000 Rockville Pike
Jun 5, 2014
Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL), Other Glivec/Gleevec
Terminated
- Chronic Myeloid Leukemia (CML)
- +2 more
-
Moscow, Russian FederationNovartis Investigative Site
Mar 12, 2012